Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer

Fig. 3

B7-H4 is aberrantly overexpressed in TNBC recurrence patients after neoadjuvant chemotherapy treatment. a The expression level of B7-H4 mRNA in the samples of recurrence TNBC patients compared with non-recurrence TNBC tissue samples. b B7-H4 immunostaining in the samples of recurrence TNBC patients compared with non-recurrence TNBC tissue samples (c). d Kaplan–Meier plots of overall survival in recurrence TNBC patients stratified by B7-H4 expression levels. e Kaplan–Meier plots of overall survival in recurrence TNBC patients stratified by B7-H4 expression intensity

Back to article page